Both medications have been shown to induce weight loss by decreasing hunger, slowing gastric emptying, and promoting a feeling of fullness
While rare, its serious and if you experience these symptoms, seek medical care immediately
The most extensively evaluated IGF-IR inhibitor is linsitinib (OSI-906), a dual IGF-IR/InsR inhibitor (Table 2)
If you take ADHD stimulants, monitor your heart rate and blood pressure since GLP-1 medications can interact with certain drugs
Conventional diet + exercise haven't produced durable results Type 2 diabetes, prediabetes, PCOS, or metabolic syndrome Sleep apnea, joint pain, or fertility issues tied to weight Family history of cardiovascular disease or diabetes You want a supervised, lab-monitored approach not a script-only service You want to preserve muscle while losing fat (body-composition focus) You want a Houston-based medical director, not an anonymous portal Not Appropriate For Everyone A medical consultation is required before starting any program
Lillys Retatrutide delivers up to 24.2% weight loss in Phase 2 trials
